USA Financial Formulas’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
USA Financial Formulas's BMY Position: Q1 2026 in Review
USA Financial Formulas opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 2,978 shares worth $181K. The stake represents 0.03% of the portfolio and ranks #127 among its holdings. This is a return to the name: USA Financial Formulas previously reported a position in BMY as recently as Q3 2023.
USA Financial Formulas first reported a position in BMY in Q2 2015 and has held it in 18 quarters since. The position peaked at $4.08M in Q2 2015. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- USA Financial Formulas held 2,978 shares of Bristol-Myers Squibb worth $181K as of Q1 2026.
- Bristol-Myers Squibb was a new USA Financial Formulas position in Q1 2026.
- Bristol-Myers Squibb made up 0.03% of USA Financial Formulas's portfolio in Q1 2026, its #127 holding.
- USA Financial Formulas first reported a position in Bristol-Myers Squibb in Q2 2015 and has held it in 18 quarters since.
- USA Financial Formulas's Bristol-Myers Squibb position peaked at $4.08M in Q2 2015.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on USA Financial Formulas's 13F filing for Q1 2026, filed 14 Apr 2026.